Japer Therapeutics Warrants
JSPRW
35 hedge funds and large institutions have $4.51M invested in Japer Therapeutics Warrants in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 1 closing their positions.
1,000% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 1
40% more funds holding
Funds holding: 25 → 35 (+10)
34% more capital invested
Capital invested by funds: $3.37M → $4.51M (+$1.15M)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
|
+$240K |
| 2 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
+$97.8K |
| 3 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
+$61.2K |
| 4 |
Walleye Capital
New York
|
+$51.8K |
| 5 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
+$42.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$72K |
| 2 |
LIM
Longfellow Investment Management
Boston,
Massachusetts
|
-$18.6K |
| 3 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$8.93K |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$5.74K |
| 5 |
BI
Bulldog Investors
Saddle Brook,
New Jersey
|
-$1.77K |
JSPRW Hedge Fund Activity: Q3 2020 in Review
35 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Japer Therapeutics Warrants (JSPRW) for Q3 2020, worth a combined $4.51M — up 34% from $3.37M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new JSPRW positions and 1 closed out — a net gain of 10 holders — while 4 added to existing stakes and 6 trimmed.
The largest buyer was P. Schoenfeld Asset Management (PSAM), opening a new position worth an estimated $240K. The largest seller was Wolverine Asset Management, exiting entirely with an estimated $72K sold.
- 35 institutional investors held Japer Therapeutics Warrants (JSPRW) as of Q3 2020, up from 25 in Q2 2020.
- Funds reported $4.51M of Japer Therapeutics Warrants stock for Q3 2020, up 34% quarter-over-quarter.
- 11 funds opened new Japer Therapeutics Warrants positions in Q3 2020 and 1 closed out, a net change of +10 holders.
- The largest Japer Therapeutics Warrants buyer in Q3 2020 was P. Schoenfeld Asset Management (PSAM), an estimated $240K added.
- The largest Japer Therapeutics Warrants seller in Q3 2020 was Wolverine Asset Management, an estimated $72K sold.
Based on aggregated 13F filings for Q3 2020.